Adolescent and Young Adult Cancer Research Studies

Show All

Medulloblastoma 

New Diagnosis  Relapse / Refractory 

Low-Grade Glioma 

New Diagnosis  Relapse / Refractory 

DIPG / High-Grade Glioma 

New Diagnosis  Relapse / Refractory 

Ependymoma 

New Diagnosis  Relapse / Refractory 

Neurofibromatosis 

Sarcoma / MPNST New Diagnosis Sarcoma / MPNST Relapse / Refractory 
NF2  Plexiform Neurofibroma  
OPG / Low-Grade Glioma  Other Neurofibromatosis  

Other Brain and Spinal Tumors

ATRT  Craniopharyngioma 
Germ Cell Tumor  Choroid Plexus Tumor 
All Other   

Osteosarcoma 

New Diagnosis  Relapse / Refractory 

Ewing Sarcoma 

New Diagnosis  Relapse / Refractory 

Rhabdomyosarcoma 

New Diagnosis  Relapse / Refractory 

Retinoblastoma

New Diagnosis  Relapse / Refractory 

Neurofibromatosis 

Sarcoma / MPNST New Diagnosis  Sarcoma / MPNST Relapse / Refractory 
NF2  Plexiform Neurofibroma 
OPG / Low-Grade Glioma  Other Neurofibromatosis 

Melanoma 

New Diagnosis  Relapse / Refractory 

Germ Cell Tumor 

New Diagnosis   Relapse / Refractory

All Other Solid Tumors 

All Other

Contact Us

Contact us.

To learn more about available clinical trials, contact us at cancer@cchmc.org or 513-636-2799.

The Cancer and Blood Diseases Institute closely integrates patient care and research to advance knowledge and improve outcomes for our patients. We are known for offering the most advanced therapies − some of which were originally developed here by nationally recognized specialists.

The Oncology Division is a national referral center for specialized leading-edge care of children and young adults with cancer and leukemia and for multidisciplinary long-term follow-up of cancer survivors.